1. Home
  2. AYTU vs GWAV Comparison

AYTU vs GWAV Comparison

Compare AYTU & GWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • GWAV
  • Stock Information
  • Founded
  • AYTU N/A
  • GWAV 2002
  • Country
  • AYTU United States
  • GWAV United States
  • Employees
  • AYTU N/A
  • GWAV N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • GWAV Packaged Foods
  • Sector
  • AYTU Health Care
  • GWAV Consumer Staples
  • Exchange
  • AYTU Nasdaq
  • GWAV Nasdaq
  • Market Cap
  • AYTU 11.8M
  • GWAV 12.6M
  • IPO Year
  • AYTU N/A
  • GWAV N/A
  • Fundamental
  • Price
  • AYTU $2.00
  • GWAV $0.21
  • Analyst Decision
  • AYTU
  • GWAV
  • Analyst Count
  • AYTU 0
  • GWAV 0
  • Target Price
  • AYTU N/A
  • GWAV N/A
  • AVG Volume (30 Days)
  • AYTU 4.1M
  • GWAV 1.7M
  • Earning Date
  • AYTU 05-14-2025
  • GWAV 06-13-2025
  • Dividend Yield
  • AYTU N/A
  • GWAV N/A
  • EPS Growth
  • AYTU N/A
  • GWAV N/A
  • EPS
  • AYTU N/A
  • GWAV N/A
  • Revenue
  • AYTU $77,691,000.00
  • GWAV $33,315,859.00
  • Revenue This Year
  • AYTU N/A
  • GWAV N/A
  • Revenue Next Year
  • AYTU $4.60
  • GWAV N/A
  • P/E Ratio
  • AYTU N/A
  • GWAV N/A
  • Revenue Growth
  • AYTU N/A
  • GWAV N/A
  • 52 Week Low
  • AYTU $0.95
  • GWAV $0.12
  • 52 Week High
  • AYTU $3.21
  • GWAV $3.88
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 60.38
  • GWAV 53.75
  • Support Level
  • AYTU $1.46
  • GWAV $0.18
  • Resistance Level
  • AYTU $2.70
  • GWAV $0.23
  • Average True Range (ATR)
  • AYTU 0.17
  • GWAV 0.02
  • MACD
  • AYTU -0.04
  • GWAV 0.00
  • Stochastic Oscillator
  • AYTU 60.67
  • GWAV 63.33

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About GWAV Greenwave Technology Solutions Inc.

Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.

Share on Social Networks: